Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | PPARG | P37231 | 4/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2258630 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL5164976 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2228492 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL4444012 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL1129946 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2258628 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL1129947 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL4746641 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2901187 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2900343 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820383-B2 | Method for diagnosing myocardial infarction | INTERLEUKIN GENETICS, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| EP-2217725-A2 | DIAGNOSTICS FOR AGING-RELATED DERMATOLOGIC DISORDERS | Interleukin Genetics, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009061506-A9 | DIAGNOSTICS FOR AGING-RELATED DERMATOLOGIC DISORDERS | INTERLEUKIN GENETICS, INC. (US) | 2009-09-11 | — | — | WO | disclosed |
| US-20090191564-A1 | DIAGNOSTICS AND THERAPEUTICS FOR CARDIOVASCULAR DISORDERS | FRANCIS SHEILA | 2009-07-30 | — | — | US | disclosed |
| US-20090170105-A1 | Diagnostics for Aging-Related Dermatologic Disorders | INTERLEUKIN GENETICS, INC. (US) | 2009-07-02 | — | — | US | disclosed |
| EP-2071040-A2 | Diagnostics and therapeutics for vascular disease | Medical Science System, Inc. (US) | 2009-06-17 | — | — | EP | disclosed |
| WO-2009061506-A2 | DIAGNOSTICS FOR AGING-RELATED DERMATOLOGIC DISORDERS | INTERLEUKIN GENETICS, INC. (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20090093396-A1 | DIAGNOSTICS AND THERAPEUTICS FOR RESTENOSIS | CROSSMAN DAVID C | 2009-04-09 | — | — | US | disclosed |
| EP-1192279-B1 | DIAGNOSTICS FOR FRAGILE PLAQUE DISORDER | INTERLEUKIN GENETICS INC (US) | 2008-09-03 | — | — | EP | disclosed |
| US-20080199865-A1 | Methods for Detecting and Treating the Early Onset of Aging-Related Conditions | CROSSMAN DAVID C | 2008-08-21 | — | — | US | disclosed |
| EP-1409737-A2 | METHODS FOR DETECTING AND TREATING THE EARLY ONSET OF AGING-RELATED CONDITIONS | Interleukin Genetics, Inc. (US) | 2004-04-21 | — | — | EP | disclosed |
| US-6720141-B1 | DETERMINING WHETHER SOMEONE IS HAS OR IS PREDISPOSED TO DEVELOPING RESTENOSIS, COMPRISING DETECTING IL-1RN(VNTR) ALLELE 1 IN A NUCLEIC ACID SAMPLE FROM THE SUBJECT | INTERLEUKIN GENETICS, INC. | 2004-04-13 | — | — | US | disclosed |
| US-20030175764-A1 | Diagnostics and therapeutics for cardiovascular disease | INTERLEUKIN GENETICS, INC. | 2003-09-18 | — | — | US | disclosed |
| US-20030152947-A1 | Methods for detecting and treating the early onset of aging-related conditions | INTERLEUKIN GENETICS, INC. | 2003-08-14 | — | — | US | disclosed |
| US-6524795-B1 | Detection of one or more alleles associated with a single vessel occlusive disorder of fragile plaque syndrome | INTERLEUKIN GENETICS, INC. | 2003-02-25 | — | — | US | disclosed |
| WO-2002103031-A2 | METHODS FOR DETECTING AND TREATING THE EARLY ONSET OF AGING-RELATED CONDITIONS | INTERLEUKIN GENETICS, INC. (US) | 2002-12-27 | — | — | WO | disclosed |
| EP-1192279-A2 | DIAGNOSTICS AND THERAPEUTICS FOR CARDIOVASCULAR DISORDERS | Interleukin Genetics, Inc. (US) | 2002-04-03 | — | — | EP | disclosed |
| EP-1127168-A2 | METHOD FOR DETERMINING THE SUSCEPTIBILITY TO DEVELOPING SEPSIS AND THERAPEUTICS FOR THE TREATMENT OF SEPSIS | Interleukin Genetics, Inc. (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000072015-A2 | DIAGNOSTICS AND THERAPEUTICS FOR CARDIOVASCULAR DISORDERS | INTERLEUKIN GENETICS, INC. (US) | 2000-11-30 | — | — | WO | disclosed |
| WO-2000037679-A2 | METHOD FOR DETERMINING THE SUSCEPTIBILITY TO DEVELOPING SEPSIS AND THERAPEUTICS FOR THE TREATMENT OF SEPSIS | INTERLEUKIN GENETICS, INC. (US) | 2000-06-29 | — | — | WO | disclosed |